Combatting Mycophenolate Risks in the Military Community: An Impactful Microlearning Approach to Strengthen the Delivery of REMS Compliant Care

CE Information

2.0 CE credits (2.0 pharmacology)

Completion Time

2 hours

Available Until

October 27, 2026

Posted By

AKH Inc., Advancing Knowledge in Healthcare

Ready to start this activity?

Navigate

Overview

Specialties

Acute Care, Adult, Family, NP Student, Oncology, Pediatric, and Women's Health

Clinical Topics

REMS

This Mycophenolate REMS-compliant activity was designed to educate healthcare providers about the management of female patients of reproductive potential who are prescribed mycophenolate — particularly those professionals who care/may care for active military members and Veterans. Female members of the Military Community are at a high risk for autoimmune disease and are likely to be prescribed mycophenolate during their child-bearing years. Studies have shown that women in the Military Community often do not receive risk-lowering care when prescribed teratogenic medications like mycophenolate. This microlearning activity provides comprehensive education on reducing the risk of embryofetal toxicity associated with the use of mycophenolate during pregnancy in eight 15-minute episodes. Each episode will be presented as a video, audio-only file, or monograph to allow the learner to create an optional learning experience that best aligns with their learning style.

Commercial Support
This activity is supported by an independent educational grant from the Mycophenolate REMS Group. This activity is intended to be fully compliant with the Mycophenolate REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Learning Objectives

After completing of the educational activity, participants should be able to:

Identify the increased risks of first trimester pregnancy loss and congenital malformations associated with mycophenolate.
Develop strategies for educating females of reproductive potential about the risks of exposure to mycophenolate during pregnancy.
Plan the management of mycophenolate in females of reproductive potential.
Summarize provider responsibilities for reporting pregnancies to the Mycophenolate Pregnancy Registry and the importance of patient participation in the Mycophenolate Pregnancy Registry.

CE Information

This activity offers 2.0 CE credits (2.0 pharmacology) to attendees.

Accredited by AKH - ACCME, AAPA, AANP, ANCC, ACPE.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare, Veterans Health and Wellness Foundation (VHWF) and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 2 Interprofessional Continuing Education (IPCE) credit for learning and change.

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 2 contact hours.

Nursing
Credit being awarded: 2 ANCC contact hours

Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2 AAPA Category 1 CME credits. Approval is valid until 10/27/2026. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare, Veterans Health and Wellness Foundation (VHWF) and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 2 contact hour(s) (which includes 2 hour(s) of pharmacology).

Available Credit

2.00 Attendance

Ready to start this activity?

Login required. You will be redirected to an external website to register for and complete this activity.

Back to navigate